Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis

Spine

Volumn 38, Issue 12, 2013, Pages

  Park, Daniel K ^a   Kim, Sung S ^b   Thakur, Nikhil ^c   Boden, Scott D ^d  

^a William Beuamont Hospital   (United States)

^b Inje University College of Medicine   (South Korea)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

BMP 2; Iliac crest; Posterolateral fusion

Indexed keywords

COLLAGEN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; DRUG CARRIER; RECOMBINANT PROTEIN;

ARTICLE; BONE GRAFT; BONE MASS; CLINICAL STUDY; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; ILIAC CREST BONE GRAFT; INTERMETHOD COMPARISON; LOCAL BONE GRAFT; MAJOR CLINICAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSTERIOR SPINE FUSION; PRIORITY JOURNAL; SPONDYLOLISTHESIS; TREATMENT OUTCOME; VERTEBRAL CANAL STENOSIS; AUTOGRAFT; BONE TRANSPLANTATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECTS; ILIAC BONE; LUMBAR VERTEBRA; OFF LABEL DRUG USE; PROCEDURES; PROSPECTIVE STUDY; RADIOGRAPHY; SPINE FUSION; SURGICAL SPONGE; TIME; TRANSPLANTATION; VALIDATION STUDY;

AUTOGRAFTS; BONE MORPHOGENETIC PROTEIN 2; BONE TRANSPLANTATION; DRUG CARRIERS; HUMANS; ILIUM; LUMBAR VERTEBRAE; OFF-LABEL USE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SPINAL FUSION; SPONDYLOLISTHESIS; SURGICAL SPONGES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84879095112     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31828fd23c     Document Type: Article

References (52)

1. Fitzgerald JA, Newman PH. Degenerative spondylolisthesis. J Bone Joint Surg Br 1976; 58: 184-92.
2. McAfee PC, Yuan HA. Computed tomography in spondylolisthesis. Clin Orthop Relat Res 1982; 166: 62-71.
3. Brown MD, Lockwood JM. Degenerative spondylolisthesis. Instr Course Lect 1983; 32: 162-9.
4. Johnson JR, Kirwan EO. The long-term results of fusion in situ for severe spondylolisthesis. J Bone Joint Surg Br 1983; 65: 43-6.
5. Dall BE, Rowe DE. Degenerative spondylolisthesis. Its surgical management. Spine (Phila Pa 1976) 1985; 10: 668-72.
6. Feffer HL, Wiesel SW, Cuckler JM, et al. Degenerative spondylolisthesis. To fuse or not to fuse. Spine (Phila Pa 1976) 1985; 10: 287-9.
7. Lombardi JS, Wiltse LL, Reynolds J, et al. Treatment of degenerative spondylolisthesis. Spine (Phila Pa 1976) 1985; 10: 821-7.
8. Chang KW, McAfee PC. Degenerative spondylolisthesis and degenerative scoliosis treated with a combination segmental rod-plate and transpedicular screw instrumentation system: a preliminary report. J Spinal Disord 1988; 1: 247-56.
9. Bolesta MJ, Bohlman HH. Degenerative spondylolisthesis. Instr Course Lect 1989; 38: 157-65.
10. Herron LD, Trippi AC. L4-5 degenerative spondylolisthesis. The results of treatment by decompressive laminectomy without fusion. Spine (Phila Pa 1976) 1989; 14: 534-8.
11. Knox BD, Harvell JC Jr, Nelson PB, et al. Decompression and luque rectangle fusion for degenerative spondylolisthesis. J Spinal Disord 1989; 2: 223-8.
12. Kim SS, Denis F, Lonstein JE, et al. Factors affecting fusion rate in adult spondylolisthesis. Spine (Phila Pa 1976) 1990; 15: 979-84.
13. Hambly MF, Wiltse LL, Peek RD, et al. Unilateral lumbar fusion. Spine (Phila Pa 1976) 1991; 16 (suppl.6) : S295-7.
14. Satomi K, Hirabayashi K, Toyama Y, et al. A clinical study of degenerative spondylolisthesis. Radiographic analysis and choice of treatment. Spine (Phila Pa 1976) 1992; 17: 1329-36.
15. Frymoyer JW. Degenerative spondylolisthesis: diagnosis and treatment. J Am Acad Orthop Surg 1994; 2: 9-15.
16. Herkowitz HN, Sidhu KS. Lumbar spine fusion in the treatment of degenerative conditions: current indications and recommendations. J Am Acad Orthop Surg 1995; 3: 123-35.
17. Fischgrund JS, Mackay M, Herkowitz HN, et al. 1997 Volvo Award winner in clinical studies. Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation. Spine (Phila Pa 1976) 1997; 22: 2807-12.
18. Bono CM, Lee CK. The influence of subdiagnosis on radiographic and clinical outcomes after lumbar fusion for degenerative disc disorders: an analysis of the literature from two decades. Spine (Phila Pa 1976) 2005; 30: 227-34.
19. Rousseau MA, Lazennec JY, Bass EC, et al. Predictors of outcomes after posterior decompression and fusion in degenerative spondylolisthesis. Eur Spine J 2005; 14: 55-60.
20. Arrington ED, Smith WJ, Chambers HG, et al. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996; 329: 300-9.
21. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine (Phila Pa 1976) 1995; 20: 1055-60.
22. Fernyhough JC, Schimandle JJ, Weigel MC, et al. Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine (Phila Pa 1976) 1992; 17: 1474-80.
23. Summers BN, Eisenstein SM. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 1989; 71: 677-80.
24. Kurz LT, Garfin SR, Booth RE Jr. Harvesting autogenous iliac bone grafts. A review of complications and techniques. Spine (Phila Pa 1976) 1989; 14: 1324-31.
25. Urist MR, Lietze A, Mizutani H, et al. A bovine low molecular weight bone morphogenetic protein (BMP) fraction. Clin Orthop Relat Res 1982; 162: 219-32.
26. Urist MR, Lindholm TS, Mirra JM, et al. Growth of osteoid osteoma transplanted into athymic nude mice. Clin Orthop Relat Res 1979; 141: 275-80.
27. Urist MR, Mikulski AJ, Nakagawa M, et al. A bone matrix calcification-initiator noncollagenous protein. Am J Physiol 1977; 232: C115-27.
28. Urist MR, Nakata N, Felser JM, et al. An osteosarcoma cell and matrix retained morphogen for normal bone formation. Clin Orthop Relat Res 1977; 124: 251-66.
29. Urist MR, Nillsson OS, Hudak R, et al. Immunologic evidence of a bone morphogenetic protein in the milieu interieur. Ann Biol Clin (Paris) 1985; 43: 755-66.
30. Vaccaro AR, Patel T, Fischgrund J, et al. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 2003; 12: 495-500.
31. Vaccaro AR, Patel T, Fischgrund J, et al. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 2005; 14: 623-9.
32. Vaccaro AR, Patel T, Fischgrund J, et al. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine (Phila Pa 1976) 2004; 29: 1885-92.
33. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine (Phila Pa 1976) 2000; 25: 376-81.
34. Burkus JK, Gornet MF, Dickman CA, et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002; 15: 337-49.
35. Burkus JK, Heim SE, Gornet MF, et al. Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device. J Spinal Disord Tech 2003; 16: 113-22.
36. Burkus JK, Heim SE, Gornet MF, et al. The effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies. Orthopedics 2004; 27: 723-8.
37. Burkus JK, Transfeldt EE, Kitchel SH, et al. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) 2002; 27: 2396-408.
38. Glassman SD, Carreon L, Djurasovic M, et al. Posterolateral lumbar spine fusion with INFUSE bone graft. Spine J 2007; 7: 44-9.
39. Glassman SD, Carreon LY, Djurasovic M, et al. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age. Spine (Phila Pa 1976) 2008; 33: 2843-9.
40. Singh K, Smucker JD, Gill S, et al. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spinal Disord Tech 2006; 19: 416-23.
41. Dawson E, Bae HW, Burkus JK, et al. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am 2009; 91: 1604-13.
42. Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine (Phila Pa 1976) 2006; 31: 2534-9; discussion 40.
43. Ohtori S, Suzuki M, Koshi T, et al. Single-level instrumented posterolateral fusion of the lumbar spine with a local bone graft versus an iliac crest bone graft: a prospective, randomized study with a 2-year follow-up. Eur Spine J 2011; 20: 635-9.
44. Sengupta DK, Truumees E, Patel CK, et al. Outcome of local bone versus autogenous iliac crest bone graft in the instrumented posterolateral fusion of the lumbar spine. Spine (Phila Pa 1976) 2006; 31: 985-91.
45. Fischgrund JS. The argument for instrumented decompressive posterolateral fusion for patients with degenerative spondylolisthesis and spinal stenosis. Spine (Phila Pa 1976) 2004; 29: 173-4.
46. Thomsen K, Christensen FB, Eiskjaer SP, et al. 1997 Volvo Award winner in clinical studies. The effect of pedicle screw instrumentation on functional outcome and fusion rates in posterolateral lumbar spinal fusion: a prospective, randomized clinical study. Spine (Phila Pa 1976) 1997; 22: 2813-22.
47. Kang J, An H, Hilibrand A, et al. Grafton and local bone have comparable outcomes to iliac crest bone in instrumented single-level lumbar fusions. Spine (Phila Pa 1976) 2012; 37: 1083-91.
48. Joseph V, Rampersaud YR. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis. Spine (Phila Pa 1976) 2007; 32: 2885-90.
49. Villavicencio AT, Burneikiene S, Nelson EL, et al. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. J Neurosurg Spine 2005; 3: 436-43.
50. McClellan JW, Mulconrey DS, Forbes RJ, et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006; 19: 483-6.
51. Poynton AR, Lane JM. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976) 2002; 27 (suppl 1) : S40-8.
52. Mindea SA, Shih P, Song JK. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review. Spine (Phila Pa 1976) 2009; 34 1480-4; discussion 5.